Kaposi’s Sarcoma Herpesvirus Genome Persistence

Kaposi’s Sarcoma Herpesvirus Genome Persistence

Kaposi’s sarcoma-associated herpesvirus (KSHV) has an etiologic role in Kaposi’s sarcoma, primary effusion lymphoma and multicentric Castleman’s disease. These diseases are most common in immunocompromised individuals, especially those with AIDS. Similar to all herpesviruses, KSHV infection is lifel...

Full description

Bibliographic Details
Main Authors:	Franceline Juillard, Min Tan, Shijun Li, Kenneth M. Kaye
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-08-01
Series:	Frontiers in Microbiology
Subjects:	KSHV DNA binding latency-associated nuclear antigen (LANA) chromosome viral persistence
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.01149/full

Similar Items

Pathology of Kaposi's sarcoma-associated herpesvirus infection
by: Hitomi eFukumoto, et al.
Published: (2011-08-01)

Kaposi’s sarcoma-associated herpesvirus genome replication, partitioning, and maintenance in latency
by: Eriko eOhsaki, et al.
Published: (2012-01-01)

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications
by: Marion Gruffaz, et al.
Published: (2018-07-01)

Nucleolin Regulates the Expression of Kaposi’s Sarcoma-Associated Herpesvirus’ Latency-Associated Nuclear Antigen through G-Quadruplexes in the mRNA
by: Andrew R. Zareie, et al.
Published: (2023-12-01)

Proteomic Profiling Identifies Kaposi’s Sarcoma-Associated Herpesvirus (KSHV)-Encoded LANASIM-Associated Proteins in Hypoxia
by: Xiaoqing Liu, et al.
Published: (2021-12-01)

Brd/BET Proteins Influence the Genome-Wide Localization of the Kaposi’s Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus Major Latency Proteins
by: Rishikesh Lotke, et al.
Published: (2020-10-01)

Targeting the Kaposi’s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells
by: Coral Orel Haddad, et al.
Published: (2021-03-01)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
by: Aude Jary, et al.
Published: (2021-12-01)

KSHV genome replication and maintenance
by: Pravinkumar ePurushothaman, et al.
Published: (2016-02-01)

Kaposi's sarcoma-associated herpesvirus at 27
by: Marta Maria Gaglia
Published: (2021-12-01)

Treatment of Kaposi sarcoma-associated herpesvirus (KSHV)-associated cancers
by: Dirk P Dittmer, et al.
Published: (2012-04-01)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
by: Chen Gam ze Letova, et al.
Published: (2021-11-01)

Arachidonic Acid Derived Lipid Mediators Influence Kaposi’s Sarcoma-Associated Herpesvirus Infection and Pathogenesis
by: Jayashree A. Chandrasekharan, et al.
Published: (2019-03-01)

Kaposi’s Sarcoma-associated herpesvirus microRNAs
by: Eva eGottwein
Published: (2012-05-01)

Lytic Reactivation of the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations
by: Nofar Atari, et al.
Published: (2022-08-01)

Dimethyl Sulfoxide Enhances Kaposi’s Sarcoma-Associated Herpesvirus Production During Lytic Replication
by: Su-Kyung Kang, et al.
Published: (2021-12-01)

For the future studies of Kaposi’s sarcoma-associated herpesvirus
by: Keiji eUeda
Published: (2012-07-01)

The ubiquitin system and Kaposi’s sarcoma-associated herpesvirus
by: Akira eAshizawa, et al.
Published: (2012-02-01)

Modulation of immune system by Kaposi’s sarcoma-associated herpesvirus:Lessons from viral evasion strategies
by: Hye-Ra eLee, et al.
Published: (2012-03-01)

Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update
by: Yan Yuan, et al.
Published: (2017-04-01)

Genotypic Analysis of Kaposi’s Sarcoma-Associated Herpesvirus from Patients with Kaposi’s Sarcoma in Xinjiang, China
by: Xinxing Ouyang, et al.
Published: (2014-11-01)

Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus
by: Veenu Minhas, et al.
Published: (2014-11-01)

Importance of Promyelocytic Leukema Protein (PML) for Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication
by: Md. Golzar Hossain, et al.
Published: (2018-10-01)

An Update of the Virion Proteome of Kaposi Sarcoma-Associated Herpesvirus
by: Ramina Nabiee, et al.
Published: (2020-12-01)

The Chromatin Landscape of Kaposi’s Sarcoma-Associated Herpesvirus
by: Zsolt Toth, et al.
Published: (2013-05-01)

FUS Negatively Regulates Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression
by: William Dunker, et al.
Published: (2018-07-01)

Role of Host MicroRNAs in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis
by: Zhiqiang Qin, et al.
Published: (2014-11-01)

Interaction and assembly of the DNA replication core proteins of Kaposi’s sarcoma-associated herpesvirus
by: Lee-Wen Chen, et al.
Published: (2023-12-01)

Epigenetic Reprogramming of Kaposi’s Sarcoma-Associated Herpesvirus during Hypoxic Reactivation
by: Rajnish Kumar Singh, et al.
Published: (2022-11-01)

Kaposi's sarcoma associated herpesvirus (KSHV) entry into target cells
by: Sayan eChakraborty, et al.
Published: (2012-01-01)

Role of Histamine and Related Signaling in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis
by: Jungang Chen, et al.
Published: (2023-04-01)

Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) – review
by: Iftode Nicoleta, et al.
Published: (2020-12-01)

Recent Advances in Developing Treatments of Kaposi’s Sarcoma Herpesvirus-Related Diseases
by: Eleonora Naimo, et al.
Published: (2021-09-01)

TEGUMENT PROTEINS OF KAPOSI’S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) AND RELATED GAMMA-HERPESVIRUSES
by: Narayanan eSathish, et al.
Published: (2012-03-01)

How Epstein–Barr Virus and Kaposi’s Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell
by: Arthur U. Sugden, et al.
Published: (2021-07-01)

Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus
by: Jungang Chen, et al.
Published: (2022-11-01)

Kaposi’s Sarcoma-Associated Herpesvirus and Host Interaction by the Complement System
by: Seung-Min Yoo, et al.
Published: (2020-04-01)

Seroprevalence and risk factors for Kaposi’s Sarcoma associated herpesvirus among men who have sex with men in Shanghai, China
by: Yi Li, et al.
Published: (2023-01-01)

Disruption of the Interaction between ORF33 and the Conserved Carboxyl-Terminus of ORF45 Abolishes Progeny Virion Production of Kaposi Sarcoma-Associated Herpesvirus
by: Joseph Gillen, et al.
Published: (2021-09-01)

Thymus capitatus flavonoids inhibit infection of Kaposi's sarcoma‐associated herpesvirus
by: Marwa Mekni‐Toujani, et al.
Published: (2022-06-01)